Related Articles
Molnupiravir – an antiviral for COVID-19
An antiviral medication could soon be available for treating COVID-19. Molnupiravir, an antiviral medication that is currently in clinical trials, may soon be added to the currently available tools to treat COVID-19. Molnupiravir is an antiviral that is different from the currently used remdesivir because unlike remdesivir, which is given via IV, molnupiravir can be […]
Most fully vaccinated people who get Covid delta infections are asymptomatic, WHO says
World Health Organization Director-General Tedros Adhanom Ghebreyesus R speaks at a daily briefing in Geneva, Switzerland. Chen Junxia | Xinhua News Agency | Getty Images People who are fully vaccinated against Covid-19 are still getting infected with the delta variant, but global health officials said the shots have protected most people from getting severely sick […]
Key features of SARS-CoV-2 infection
New research develops vital animal model of SARS-CoV-2 to help identify the key features of infection. The development of effective therapies to treat COVID-19 is a problem of immense global significance. However, one of the key steps in the development of a novel therapeutic is the development of a reliable animal model that can be […]